Test Code 3017
New York approved

Dystonia Panel

17 genes

2 - 3 weeks (6 - 12 days STAT)

Who is this test for?
  • Individuals with relevant features who have a clinical or suspected diagnosis of dystonia 
  • Individuals with symptom onset before age 20 years  
  • Individuals of Ashkenazi Jewish ancestry with early-onset generalized dystonia 
  • Individuals with dystonia who show sustained response to levodopa treatment
Method
NGS with CNV (Exome or Genome Platform)
Specimen(s)

Exome Platform: Blood, DNA, Buccal, Saliva, Tissue

Genome Platform: Blood, DNA

Order Options

OTHER OPTIONS
for standard institutional pricing.

Explore related tests

Questions? We can help.

Getting support has never been easier. Let us connect you with our specialists that will assist you with anything from understanding products to navigating insurance questions.